logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

"Inflation fighter" to be launched soon? Bank of Japan's 25 basis points rate hike next week may be a foregone conclusion.

date
10/06/2026
The Securities Times app has learned that according to observers of the Bank of Japan, the bank is expected to raise the benchmark interest rate twice this year - with the first increase happening next week - as they increasingly believe that the situation in Iran could lead to sustained high inflation.
Latest
3 m ago
The Kuwaiti military has announced that the air defense forces are intercepting hostile aerial targets.
6 m ago
State Council Taiwan Affairs Office: The DPP authorities' smearing of the Straits Forum exposes the essence of "false democracy, true dictatorship."
7 m ago
According to The Information, OpenAI is in talks for a 20-year lease agreement that would be its largest infrastructure investment commitment to date. Nvidia is discussing providing credit support for the project.
7 m ago
OpenAI's deal in Ohio may include an investment from Nvidia.
7 m ago
Hong Kong stock anomaly | Maiwei Biotechnology-B (02493.HK) rose more than 7% against the market trend. 9MW5211 injection clinical trial application approved by the National Medical Products Administration.
See all latestmore
logo
Contact US
qr
+852 - 60190728
[email protected]
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.